Scott Gottlieb, M.D., has ended the hiring freeze President Donald Trump imposed on the FDA.
The key to strengthening the lungs of premature babies may be held by spiders—namely, the way they spin their webs.
How PAREXEL's New Ecosystem of Technology, Processes and Expertise is Transforming Drug Development
Researchers from the University of Rochester's Center for RNA Biology are investigating CRISPR/CAS9 as a way to slow the growth of cancer cells.
Alexion bids farewell to CFO, CCO, R&D head and HR chief; Illumina's interim CCO became permanent; INC Research unveiled new executive team.
With pressures to fast-track clinical development, the pharmaceutical industry recognizes the value of improving internal clinical data management processes.…
Harpoon Therapeutics has raised $45 million in its second funding round as it looks to get its I-O candidates into the clinic as well as boosting its pipeline…
GW Pharma's cannabis-based epilepsy treatment Epidiolex is firmly on track for a filing in the U.S. after new data published in the New England Journal of…
Redx has suspended trading of its shares after a creditor stepped up its attempt to recoup a loan.
A panel of experts voted 12 to 4 in favor of approving Puma's breast cancer adjuvant therapy neratinib.
Merck has today penned a new licensing deal with Tokyo’s Teijin Pharma for its investigational tau-targeting antibody candidate in Alzheimer’s.
The big China CRO WuXi Biologics is slated for an initial public offering of up to $513 million in Hong Kong.